IRIS
FARGNOLI, MARIA CONCETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.619
EU - Europa 5.998
AS - Asia 4.508
SA - Sud America 506
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 12
Totale 20.694
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.578
IE - Irlanda 1.832
SG - Singapore 1.496
CN - Cina 1.218
TR - Turchia 847
RU - Federazione Russa 827
SE - Svezia 776
HK - Hong Kong 738
DE - Germania 601
UA - Ucraina 483
BR - Brasile 452
GB - Regno Unito 450
IT - Italia 413
FI - Finlandia 270
FR - Francia 136
IN - India 51
CZ - Repubblica Ceca 49
BE - Belgio 43
VN - Vietnam 41
ES - Italia 29
CA - Canada 23
AR - Argentina 21
EU - Europa 18
NL - Olanda 18
AU - Australia 11
BD - Bangladesh 11
ZA - Sudafrica 11
IQ - Iraq 10
MX - Messico 10
PK - Pakistan 10
IL - Israele 9
LT - Lituania 9
AT - Austria 8
JP - Giappone 8
KR - Corea 8
MA - Marocco 8
TW - Taiwan 8
UZ - Uzbekistan 8
HU - Ungheria 7
PE - Perù 7
AZ - Azerbaigian 6
CO - Colombia 6
ID - Indonesia 6
VE - Venezuela 6
JO - Giordania 5
RS - Serbia 5
AL - Albania 4
BY - Bielorussia 4
CL - Cile 4
CR - Costa Rica 4
DZ - Algeria 4
EC - Ecuador 4
GE - Georgia 4
KG - Kirghizistan 4
LU - Lussemburgo 4
PY - Paraguay 4
RO - Romania 4
TN - Tunisia 4
DK - Danimarca 3
EG - Egitto 3
KH - Cambogia 3
MD - Moldavia 3
MK - Macedonia 3
PL - Polonia 3
CH - Svizzera 2
CY - Cipro 2
EE - Estonia 2
GR - Grecia 2
LB - Libano 2
ME - Montenegro 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MM - Myanmar 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
Totale 20.694
Salva come PNG Salva come JPEG
Città #
Chandler 1.944
Jacksonville 1.918
Dublin 1.830
Hong Kong 732
Santa Clara 724
Boardman 690
Singapore 679
Izmir 424
Nanjing 336
Lawrence 306
Princeton 306
San Mateo 304
Wilmington 297
New York 252
Moscow 219
Ann Arbor 156
Ashburn 155
Milan 122
Woodbridge 113
Nanchang 108
Des Moines 86
Mountain View 80
Shenyang 73
Los Angeles 72
Beijing 70
Seattle 67
Helsinki 64
Tianjin 57
Hebei 55
Verona 54
L'aquila 50
Falls Church 48
Brno 45
Munich 45
Brussels 43
Kunming 42
Jiaxing 41
Jinan 40
Dearborn 37
Dong Ket 35
Norwalk 34
Dallas 32
Shanghai 31
Changsha 29
Ningbo 29
The Dalles 29
São Paulo 28
Falkenstein 27
Rome 27
Council Bluffs 23
Zhengzhou 22
London 21
L’Aquila 20
Guangzhou 19
Bremen 18
Fremont 17
Pune 17
Changchun 16
Taizhou 16
Hangzhou 15
Belo Horizonte 14
Tappahannock 13
Houston 12
Lanzhou 11
Lappeenranta 11
Pescara 11
Philadelphia 11
Redwood City 11
Amsterdam 10
Auburn Hills 9
Mumbai 9
Rio de Janeiro 9
Toronto 9
Baghdad 8
Curitiba 8
Frankfurt am Main 8
Redmond 8
Brasília 7
Campinas 7
Chapel Hill 7
Edinburgh 7
Madrid 7
Nuremberg 7
Taipei 7
Tashkent 7
Budapest 6
Fortaleza 6
Lissone 6
Amman 5
Baku 5
Cape Town 5
Fuzhou 5
Hefei 5
Hyderabad 5
Jakarta 5
Lima 5
Nancy 5
Ottawa 5
Phoenix 5
San Francisco 5
Totale 13.495
Salva come PNG Salva come JPEG
Nome #
Cutaneous metastatic breast carcinoma: A study of 164 patients 195
Rapid response of scalp psoriasis to ustekinumab 114
Parapsoriasi 106
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 104
Long-term efficacy and safety of daylight photodynamic therapy with methyl aminolevulinate for actinic keratosis of the face and scalp 101
Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study 100
Cutaneous manifestations in Italian kidney transplant recipients 100
Efficacy, tolerability and cosmetic acceptabilily of Toléderm® in patients with inflammatory cutaneous diseases of the face 98
Dermoscopic features of actinic keratosis 98
Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy 98
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy 98
Pigmented reticular structures in basal cell carcinoma and collision tumours 96
Staging and follow-up of cutaneous Melanoma patients 96
The first skin cancer screening day at the Italian parliament: a Euromelanoma initiative 95
Efficacy evaluation of an oil-in-water emulsion (Dermoflan) in atopic dermatitis 92
T-cell receptor (TCR) signal transduction: Biochemical mechanisms and possible clinical implications 92
Mucosal involvement in a patient with lymphomatoid papulosis 92
Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study 92
A variant in FTO shows association with melanoma risk not due to BMI 92
MC1R Variants Increase Risk of Melanomas harboring BRAF Mutations 92
Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant 91
Understanding the molecular genetics of basal cell carcinoma 91
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment 91
Reduced expression of CDKN2a/p16INK4a in mycosis fungoides 90
Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population 89
Diminished TCR signaling in cutaneous T-cell Iymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk 89
EDNRB gene variants and melanoma risk in two southern European populations. 88
Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family 88
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 87
Treatments of advanced basal cell carcinoma: a review of the literature 86
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study 86
MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project 86
Current psoriasis treatments in an Italian population and their association with socio-demographical and clinical features 85
MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis 85
Physicians' concerns towards prescription adherence and treatment effectiveness in the clinical management of actinic keratosis 85
MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair 85
Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy 85
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 85
Molecular genetic aspects of cutaneous melanoma 84
Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity 84
Cutaneous and mucosal melanomas of uncommon sites: Where do we stand now? 84
Acneiform follicular mucinosis of the head and neck region 83
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in Southern European populations: Results from a Meta-analysis 83
Rationale for the development of speckled hyperpigmentation in the areas of psoriatic plaques after treatment with biologic agents 83
Dermoscopic variability of basal cell carcinoma according to clinical type and anatomic location 83
Photodynamic therapy for the treatment of micro invasive squamous cell carcinoma of the lower lip: a case report 83
Nucleotide diversity and population differentiation of the melanocortin 1 receptor gene, MC1R 83
Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype 82
The spectrum of dermatoscopic patterns in blue nevi 82
Strategy for in vitro and ex-vivo testing of neutrophins signaling pathways based on immunoproteomic array profiling 82
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 81
Association of Genetic Variants in CDK6 and XRCC1 with the Risk of Dysplastic Nevi in Melanoma-Prone Families 81
CDKN2A/p16 expression in mycosis fungoides 81
Cost-effectiveness analysis of topical treatments for actinic keratosis in the perspective of the Italian health care system 81
Use of recombinant interferon alpha-2a in the treatment of squamous cell carcinoma 80
A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy 80
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs 80
Knowledge of melanoma and attitude towards moles in Italian melanoma 80
Photodynamic therapy for basal cell carcinoma 80
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics. 79
Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis 79
Hypo-epiluminescence microscopy of pigmented skin lesions. A new approach to improve recognition of dermoscopic structures 79
Pentachrome vitiligo 79
DIMINISHED ACTIVITY OF MEMBRANE-BOUND P50(CSK) IN CUTANEOUS T-CELL LYMPHOMA 79
Pilotropic mycosis fungoides presenting as an acneiform eruption 79
On the interplay of telomeres, nevi and the risk of melanoma 79
Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient, prospective, comparison study in Italy 79
Granulomatous mycosis fungoides responsive to gemcitabine 78
High-penetrance melanocortin 1 receptor gene variants contribute to sporadic cutaneous melanoma risk in the Italian population 78
Unusually large cutaneous metastases of renal cell carcinoma 78
CDKN2A alterations in patients with multiple primary melanomas 78
Cutaneous metastases of gastrointestinal malignancies 77
Mycosis fungoides. Clinical and molecular biology observations 77
Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy 77
Dermoscopic features and follow-up changes of acral melanocytic naevi in childhood and dolescence. 77
Dermoscopic features of facial pigmented actinic keratosis 77
The CDKN2A A148 T variant is not associated with melanoma risk in the French and Italian populations 77
Gli Interferoni 77
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments 77
Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma 77
Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases 77
The use of chemical peelings in the treatment of different cutaneous hyperpigmentations 76
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project 75
No evidence for linkage with melanoma in Italian melanoma-prone families 75
Figurate eruption: Erythema annulare centrifugum, deep type 75
Figurate eruption in a 69-year-old woman 75
Germline and somatic CDKN2A mutations in multiple primary melanoma patients. 75
Teledermoscopic evaluation of 50 cases of pigmented skin lesions stored with 3 different resolutions 75
Multiple microsatellite alterations on chromosome 9 in neurofibromas of NF-1 patients 75
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 75
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome 75
Topical tazarotene 0.05% versus glycolic acid 70% treatment in a patient with X-linked ichthyosis 74
CDKN2A methylation as a predisposing factor for familial melanoma 74
Genetic Susceptibility In Familial And Multiple Melanoma Patients In Central Italy 74
Efficacy of tetracycline treatment to prevent the acneiform eruption secondary to cetuximab therapy 74
CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds 74
Imiquimod treatment of superficial and nodular basal cell carcinoma: a 12-week open label trial 74
Clinical experience of imiquimod 3.75% for actinic keratosis: Results from a case series 74
Eruptive xanthomas as revealing sign of type V hyperlipoproteinemia in a patient with a psychotic syndrome 73
Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma 73
Totale 8.472
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.991
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.991
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020258 0 0 0 0 0 0 0 0 0 0 9 249
2020/20212.189 15 246 2 252 241 92 304 68 289 99 452 129
2021/20221.694 96 128 308 108 56 39 23 104 175 17 131 509
2022/20235.428 394 290 94 546 454 608 4 399 2.354 31 173 81
2023/20241.397 210 67 147 204 88 355 42 52 1 64 31 136
2024/20255.432 165 108 590 222 734 573 902 480 1.440 200 18 0
Totale 21.188